Wavefront-guided refractive surgery: promise and pitfalls
Refractive surgery in the next few years will be dominated by the intellectually and, we hope, clinically exciting introduction of wavefront-guided surgery. Both from the viewpoint of improving our current results and for the treatment of the patient suffering adverse optical sequelae after LASIK, wavefront technology offers a novel and promising diagnostic and surgical approach. Indeed, refractive surgery today-borrowing from optics, astronomy, physics, engineering, and biology-represents the ultimate fusion of science, technology, and medicine.
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.